EUVIMEDEUVIMED entdecken
Fallbericht

Cilostazol in a Child With Moyamoya Disease

Alizah A Patterson iD, Sarah K D Vogel iD, April Sharp iD, Risheng Xu, Alan Cohen, Lisa R Sun iD

Journal of Child Neurology · 2026

DOI: 10.1177/08830738251408110 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Child Neurology, 2026. Verfasst von Alizah A Patterson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodevelopmental Medicine, Kennedy Krieger Institute, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Moyamoya Disease, Cilostazol, Tetrazoles, Platelet Aggregation Inhibitors. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Moyamoya disease is characterized by progressive stenosis of the terminal internal carotid arteries and their branches with secondary angiogenesis of lenticulostriate collateral vessels. Although surgical revascularization decreases the risk of ischemic and hemorrhagic strokes, there remains little evidence demonstrating safety and efficacy of nonsurgical interventions in pediatric moyamoya. Recent data support the use of cilostazol in adult moyamoya, but cilostazol safety and efficacy in pediatric moyamoya remains unknown. We report the case of a 9-year-old girl diagnosed with MMD following a large right MCA stroke who experienced frequent transient neurologic events consisting of dysarthria and left-sided drooling after pial synangiosis. After unsuccessful trials of antiseizure medications and blood pressure augmentation, the events ultimately abated after the addition of cilostazol. Episodes recurred but again subsided after cilostazol dosing adjustment. This case suggests that cilostazol may be safe and effective for management of pediatric MMD and highlights the need for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Moyamoya DiseaseCilostazolTetrazolesPlatelet Aggregation InhibitorsHumansFemaleChildTreatment Outcome

Stichwörter der Autor:innen

AntiplateletCilostazolMoyamoyaPediatric Stroke

Substanzen

CilostazolTetrazolesPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Neurodevelopmental Medicine, Kennedy Krieger Institute, Baltimore, MD, USA.
  • Department of Neurology, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Department of Neurosurgery, The Johns Hopkins School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Alizah A Patterson, Sarah K D Vogel, April Sharp, Lisa R Sun

Zitieren

APA

Patterson, A. A., Vogel, S. K. D., Sharp, A., Xu, R., Cohen, A., & Sun, L. R. (2026). Cilostazol in a Child With Moyamoya Disease. Journal of Child Neurology. https://doi.org/10.1177/08830738251408110

Vancouver

Patterson AA, Vogel SKD, Sharp A, Xu R, Cohen A, Sun LR. Cilostazol in a Child With Moyamoya Disease. Journal of Child Neurology. 2026. doi:10.1177/08830738251408110

BibTeX
@article{Patterson2026,
  author = {Patterson, Alizah A and Vogel, Sarah K D and Sharp, April and Xu, Risheng and Cohen, Alan and Sun, Lisa R},
  title = {Cilostazol in a Child With Moyamoya Disease},
  journal = {Journal of Child Neurology},
  year = {2026},
  doi = {10.1177/08830738251408110}
}
Kostenlos starten →